• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠温度响应性水凝胶中罗哌卡因持续释放制剂的群体药代动力学分析。

Population pharmacokinetic analysis of ropivacaine extended-release from a temperature-responsive hydrogel in rats.

机构信息

Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

TGelBio Co., Ltd., Seoul, South Korea.

出版信息

Clin Exp Pharmacol Physiol. 2021 Jun;48(6):932-937. doi: 10.1111/1440-1681.13492. Epub 2021 Mar 24.

DOI:10.1111/1440-1681.13492
PMID:33686702
Abstract

Therapeutic agents with a short half-life need to be administered frequently to achieve sustained and effective concentrations. This could be accomplished using sustained drug delivery technology. PF-72 (TGel Bio, Inc., Seoul, Korea) is a drug delivery system based on a powder obtained from lyophilisation of a reverse thermal hydrogel, which could assist in achieving prolonged pain relief if mixed with an anaesthetic and injected into the incision site following surgery. The pharmacokinetic parameters related to the absorption of the local anaesthetic ropivacaine delivered using this hydrogel were quantified. Ten rats were divided into two groups (n = 5 each), and equal doses (4 mg/kg) of different formulations were subcutaneously injected into the abdomen. The experimental group received PF-72 mixed with 0.75% ropivacaine, and the control group received 0.75% ropivacaine. Blood was collected at specific times to measure the plasma concentration of ropivacaine. Population pharmacokinetic analysis was performed using NONMEM VII level 4 (ICON Development Solutions, Dublin, Ireland). The one-compartment absorption model, which combines zero-order absorption and first-order absorption, was used to describe the change in ropivacaine plasma concentration over time. The type of formulation was a significant covariate for zero-order absorption duration (experimental group, 92.9 min; control group, 60.5 min). The addition of PF-72 to 0.75% ropivacaine increased the duration of absorption into the blood, suggesting a longer lasting effect of the analgesic injected into the surgical wound.

摘要

治疗剂半衰期较短,需要频繁给药才能达到持续有效的浓度。这可以通过持续药物递送技术来实现。PF-72(TGel Bio,Inc.,韩国首尔)是一种基于冻干反向温敏水凝胶粉末的药物递送系统,如果与麻醉剂混合并在手术后注入切口部位,可能有助于实现延长的疼痛缓解。定量了使用这种水凝胶递送局部麻醉药罗哌卡因的吸收的药代动力学参数。将 10 只大鼠分为两组(每组 n=5),并将不同制剂的等量(4mg/kg)皮下注射到腹部。实验组接受 PF-72 与 0.75%罗哌卡因混合,对照组接受 0.75%罗哌卡因。在特定时间采集血液以测量罗哌卡因的血浆浓度。使用 NONMEM VII 级别 4(ICON Development Solutions,爱尔兰都柏林)进行群体药代动力学分析。将零级吸收和一级吸收相结合的单室吸收模型用于描述罗哌卡因血浆浓度随时间的变化。制剂类型是零级吸收持续时间的显著协变量(实验组 92.9 分钟;对照组 60.5 分钟)。将 PF-72 添加到 0.75%罗哌卡因中增加了血液吸收的持续时间,表明注入手术伤口的镇痛剂的作用持续时间更长。

相似文献

1
Population pharmacokinetic analysis of ropivacaine extended-release from a temperature-responsive hydrogel in rats.大鼠温度响应性水凝胶中罗哌卡因持续释放制剂的群体药代动力学分析。
Clin Exp Pharmacol Physiol. 2021 Jun;48(6):932-937. doi: 10.1111/1440-1681.13492. Epub 2021 Mar 24.
2
Preclinical studies of ropivacaine extended-release from a temperature responsive hydrogel for prolonged relief of pain at the surgical wound.用于手术切口长效止痛的温度响应水凝胶中罗哌卡因的控释的临床前研究。
Int J Pharm. 2019 Mar 10;558:225-230. doi: 10.1016/j.ijpharm.2019.01.011. Epub 2019 Jan 14.
3
Proliposomal Ropivacaine Oil: Pharmacokinetic and Pharmacodynamic Data After Subcutaneous Administration in Volunteers.前体脂质体罗哌卡因油剂:志愿者皮下给药后的药代动力学和药效学数据
Anesth Analg. 2016 May;122(5):1673-80. doi: 10.1213/ANE.0000000000001217.
4
Novel temperature-responsive hydrogel injected to the incision site for postoperative pain relief in laparoscopic abdominal surgery: a single-blind, randomized, pivotal clinical trial.新型温度响应性水凝胶注射至切口部位减轻腹腔镜腹部手术后疼痛:一项单盲、随机、关键性临床试验。
Surg Endosc. 2022 Aug;36(8):5794-5802. doi: 10.1007/s00464-022-09252-4. Epub 2022 May 12.
5
A Novel Proliposomal Ropivacaine Oil: Pharmacokinetic-Pharmacodynamic Studies After Subcutaneous Administration in Pigs.一种新型脂质体罗哌卡因油剂:猪皮下给药后的药代动力学-药效学研究
Anesth Analg. 2016 May;122(5):1663-72. doi: 10.1213/ANE.0000000000001200.
6
Construction of injectable micron-sized polymorphic vesicles for prolonged local anesthesia with weekly sustained release of ropivacaine.可注射微米级多晶型囊泡的构建用于延长局部麻醉,每周持续释放罗哌卡因。
Int J Pharm. 2024 Aug 15;661:124378. doi: 10.1016/j.ijpharm.2024.124378. Epub 2024 Jun 24.
7
Pharmacokinetics and efficacy of ropivacaine in Chinese patients following intra-articular administration.罗哌卡因关节腔内给药在中国患者中的药代动力学及疗效
Int J Clin Pharmacol Ther. 2013 May;51(5):393-400. doi: 10.5414/CP201828.
8
Ropivacaine in neonates and infants: a population pharmacokinetic evaluation following single caudal block.罗哌卡因在新生儿和婴儿中的应用:单次骶管阻滞后的群体药代动力学评估
Paediatr Anaesth. 2004 Sep;14(9):724-32. doi: 10.1111/j.1460-9592.2004.01373.x.
9
A population pharmacokinetic model for the complex systemic absorption of ropivacaine after femoral nerve block in patients undergoing knee surgery.膝关节手术患者股神经阻滞后罗哌卡因复杂全身吸收的群体药代动力学模型。
J Pharmacokinet Pharmacodyn. 2012 Dec;39(6):635-42. doi: 10.1007/s10928-012-9275-z. Epub 2012 Sep 30.
10
A Comparison of Differences Between the Systemic Pharmacokinetics of Levobupivacaine and Ropivacaine During Continuous Epidural Infusion: A Prospective, Randomized, Multicenter, Double-Blind Controlled Trial.连续硬膜外输注期间左旋布比卡因和罗哌卡因全身药代动力学差异的比较:一项前瞻性、随机、多中心、双盲对照试验。
Anesth Analg. 2015 Aug;121(2):348-56. doi: 10.1213/ANE.0000000000000775.